Brain Tumor Drugs Market to reach US$ 2.65 billion in 2023 and is expected to be worth US$ 6.30 billion by 2033 | Future Market Insights, Inc.
February 21, 2023 05:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Feb. 21, 2023 (GLOBE NEWSWIRE) -- The brain tumor drugs market is likely to grow from US$ 2.65 billion in 2023 to US$ 6.30 billion in 2033. Prevalence of smoking, stress, aging, and...
The Importance of Testing for Traumatic Brain Injuries Before It's Too Late
October 06, 2021 11:30 ET
|
Cambre & Associates
ATLANTA, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Traumatic brain injury (TBI) results from an impact to the head. Injuries can be mild or more serious and leave bruising, torn tissue, internal/external...
Oxygen Biotherapeutics Receives U.S. Army Grant for Studies of Oxycyte(R), a Novel Traumatic Brain Injury Therapeutic for Combat Casualties
March 02, 2011 02:00 ET
|
Oxygen Biotherapeutics, Inc.
MORRISVILLE, N.C., March 2, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced it has received a $2.075 million, two-year grant from the U.S....